To main content

Functional impact of Nth like DNA glycosylase 1 on mitochondrial dynamics

Abstract

Nth like DNA glycosylase 1 (NTHL1), a key base excision repair enzyme, has long been considered essential for nuclear and mitochondrial genome integrity. Combining in vitro biochemical assays, in cellulo molecular biology, and bioinformatic analyses, we investigated how NTHL1 loss affects mitochondrial DNA (mtDNA) stability and mitochondrial function. Contrary to the conventional view that mtDNA damage is solely detrimental, we find that NTHL1 loss confers a beneficial, mitochondria-initiated phenotype in human cells. Despite accumulating mtDNA lesions, NTHL1 loss unexpectedly increases mtDNA copy number, elevates oxidative phosphorylation protein levels, and enhances mitochondrial respiration. NTHL1−/− cells also show increased mitochondrial mass and higher levels of the biogenesis regulator PGC1α and the fusion protein OPA1, indicating an adaptive response that boosts mitochondrial function and capacity. Consequently, NTHL1−/− cells exhibit resistance to mitochondrial stress, accompanied by increased eIF2α phosphorylation and reduced MYC levels, converging on a broader transcriptional adaptive program. This phenotype depends on mitochondrial NTHL1 and reactive oxygen species (ROS) signaling, since treatment with ROS scavengers or mitochondria-specific reintroduction of NTHL1 rescues it. Together, these findings position NTHL1 as a key modulator of mtDNA stability and mitochondrial function, revealing that loss of this DNA repair enzyme shifts cellular metabolism toward a stress-adaptive state and enhances resilience to oxidative stress.

Category

Academic article

Language

English

Author(s)

  • Lisa Anne Hubers
  • Alexander Myhr Skjetne
  • Luisa Luna
  • Yohan Pierre Lefol
  • Solveig Osnes Lund
  • Ane Marit Wågbø
  • Xavier Renaudin
  • Annikka Virginia Polster
  • Zoe J. da Silva
  • Anders Knoph Berg-Eriksen
  • Francisco Jose Naranjo Galindo
  • Anna Campalans
  • Torkild Visnes
  • Hilde Loge Nilsen
  • Nicola Pietro Montaldo

Affiliation

  • SINTEF Industry / Biotechnology and Nanomedicine
  • Chalmers University of Technology
  • University of Paris-Saclay
  • Paris Cité University
  • Leiden University Medical Center
  • University of Oslo
  • Oslo University Hospital

Date

15.09.2026

Year

2026

Published in

Nucleic Acids Research (NAR)

ISSN

0305-1048

Volume

54

Issue

17

View this publication at Norwegian Research Information Repository